AI Article Synopsis

  • In areas where canine leishmaniosis is common, the non-pathogenic Leishmania tarentolae coexists with the harmful Leishmania infantum, raising questions about their interactions and potential immune responses in dogs.
  • The study involved infecting twelve beagle dogs with L. tarentolae to measure antibody production, immunity duration, cytokine response, and any pathogenic effects, monitoring them over 206 days.
  • Findings showed that L. tarentolae is non-pathogenic, with detectable DNA for up to three months post-infection, and suggests its potential use as a protective measure or treatment against harmful Leishmania species in dogs and possibly humans.

Article Abstract

In canine leishmaniosis endemic areas, Leishmania infantum may occur in sympatry with the non-pathogenic Leishmania tarentolae, which is associated to reptiles. The potential infectivity of L. tarentolae for mammals raises questions about the interactions between the two Leishmania species, and the potential cross-immune protection in dogs. This study aimed to assess the outcome of experimental L. tarentolae infection in dogs, determining: i) the anti-L. tarentolae antibody production, ii) the duration of the immunity and cytokine expression, and iii) the possible pathogenic effect in the canine host. Twelve purpose-bred beagle dogs were randomly allocated to three groups (intravenous inoculation, G1; intradermal inoculation, G2; negative control, G3). G1 and G2 dogs were inoculated twice (day 0, day 28) with 108 promastigotes of L. tarentolae strain (RTAR/IT/21/RI-325) isolated from a Tarentola mauritanica gecko. The animals were followed until day 206. Blood, serum, conjunctival swabs and lymph node aspirate samples were collected monthly and bone marrow, liver and spleen biopsies on day 91. Hematological and biochemical parameters were assessed monthly, as well as serology (IFAT and ELISA) and molecular identification of L. tarentolae. Mononuclear cells (PBMC) were obtained to assess the cytokine expression through in vitro stimulation or (re-) infection. Data from this study demonstrated that DNA from L. tarentolae is detectable up to 3 months post-infection, with seroconversion after day 28. Moreover, the non-pathogenic nature of L. tarentolae was confirmed, with a neutral Th1/Th2 polarization, and a possible shift to Th1 phenotype after derived macrophages (re-) infection, as demonstrated by the expression of IFN-gamma. Therefore, L. tarentolae demonstrated a great potential as a surrogate pathogen and/or immune-prophylaxis/immune-therapy against Leishmania infections in dogs and humans.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463833PMC
http://dx.doi.org/10.1371/journal.ppat.1012598DOI Listing

Publication Analysis

Top Keywords

tarentolae
10
leishmania tarentolae
8
cytokine expression
8
re- infection
8
dogs
6
day
5
saurian-associated leishmania
4
tarentolae dogs
4
dogs infectivity
4
infectivity immunogenicity
4

Similar Publications

Background: Cutaneous Leishmaniases (CL), highly endemic in Africa and Mediterranean region, are caused by different Leishmania parasite species. Accurate species identification is crucial for effective diagnosis, treatment, and control of these diseases, but traditionally relies on DNA-based methods. High Resolution Melting analysis PCR (HRM PCR) provides rapid results and precise differentiation based on nucleotide variations.

View Article and Find Full Text PDF

Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production.

J Vis Exp

November 2024

CSIRO-QUT Synthetic Biology Alliance, Queensland University of Technology; ARC Centre of Excellence in Synthetic Biology, Queensland University of Technology; Centre for Agriculture and the Bioeconomy, Queensland University of Technology; School of Biology and Environmental Science, Queensland University of Technology; Centre for Genomics and Personalised Health, Queensland University of Technology.

This protocol outlines the production and optimization of a eukaryotic Cell-Free Protein Expression System (CFPS) derived from the unicellular flagellate Leishmania tarentolae, referred to as Leishmania Translational Extract or LTE. Although this organism originally evolved as a parasite of geckos, it can be cultivated easily and inexpensively in flasks or bioreactors. Unlike Leishmania major, it is non-pathogenic to humans and does not require special laboratory precautions.

View Article and Find Full Text PDF

The detection of Leishmania tarentolae in sympatric areas where Leishmania infantum is endemic raised questions regarding the protective effect exerted in dogs by L. tarentolae when in coinfection. This study aimed monitoring the in vitro gene expression of pro- (IFN- γ; TNF-α; IL-12) and anti-inflammatory (IL-4; IL-6; IL-10) cytokines in primary canine macrophages infected by L.

View Article and Find Full Text PDF

Leishmania tarentolae as a platform for the production of vaccines against viral pathogens.

NPJ Vaccines

November 2024

Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307, Gdansk, Poland.

Infectious diseases remain a persistent public health problem and a leading cause of morbidity and mortality in both humans and animals. The most effective method of combating viral infections is the widespread use of prophylactic vaccinations, which are administered to both people at risk of disease and animals that may serve as significant sources of infection. Therefore, it is crucial to develop technologies for the production of vaccines that are highly effective, easy to transport and store, and cost-effective.

View Article and Find Full Text PDF
Article Synopsis
  • In areas where canine leishmaniosis is common, the non-pathogenic Leishmania tarentolae coexists with the harmful Leishmania infantum, raising questions about their interactions and potential immune responses in dogs.
  • The study involved infecting twelve beagle dogs with L. tarentolae to measure antibody production, immunity duration, cytokine response, and any pathogenic effects, monitoring them over 206 days.
  • Findings showed that L. tarentolae is non-pathogenic, with detectable DNA for up to three months post-infection, and suggests its potential use as a protective measure or treatment against harmful Leishmania species in dogs and possibly humans.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!